Molina Healthcare Inc (MOH) Stock Analysis
Verdict: WATCH (do not buy)
Improving Medicaid guidance and Marketplace growth are fighting a margin compression cycle and extreme P/E expansion risk.
Investment score: 46/100
Analysis as of
Is Molina Healthcare Inc stock worth reviewing? AI model thesis
Molina is navigating a difficult Medicaid redetermination cycle. Recent price action suggests technical damage that guidance alone couldn't fix.
7-factor investment score
- Valuation: 40/100 (weight 20%)
- Financial Health: 35/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 50/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 55/100 (weight 10%)
- Risk-Adjusted Return: 50/100 (weight 15%)
Molina Healthcare Inc opportunities and risks
What speaks for MOH
- Marketplace Segment Explosion
What speaks against MOH
- Severe Margin Compression
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| MOH | 1220.2x | 0.2x | 24.6x | 34.6% | -0.0% | 2.7% |
| UNH | 27.1x | 0.9x | 16.5x | 22.5% | 3.1% | 6.2% |
| ELV | 16.9x | 0.4x | 12.9x | 39.0% | 2.5% | 7.6% |
| HUM | 41.9x | 0.3x | 19.7x | 14.0% | 0.8% | 2.7% |
| CNC | n/a | 0.2x | n/a | 14.9% | -3.3% | 20.1% |
| HQY | 35.1x | 5.9x | 18.9x | 72.7% | 17.3% | 6.1% |
| Peer median | 27.1x | 0.4x | 16.5x | 22.5% | 2.5% | 6.2% |
Frequently asked questions about Molina Healthcare Inc (MOH)
Is MOH stock a good investment?
The cached TradeMates AI model rates Molina Healthcare Inc as WATCH (do not buy) with an investment score of 46/100. Molina is navigating a difficult Medicaid redetermination cycle. Recent price action suggests technical damage that guidance alone couldn't fix. This is algorithmic model output, not personal investment advice.
Is MOH stock a buy?
The TradeMates model verdict for MOH is WATCH (do not buy) with an investment score of 46/100. Treat this as a model signal to review, not a personal buy recommendation.